1 |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
|
2 |
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer[J]. Oral Oncol, 2009, 45(4/5): 309-316.
|
3 |
Xia CF, Dong XS, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J, 2022, 135(5): 584-590.
|
4 |
Parak U, Lopes Carvalho A, Roitberg F, et al. Effectiveness of screening for oral cancer and oral potentially malignant disorders (OPMD): a systematic review[J]. Prev Med Rep, 2022, 30: 101987.
|
5 |
Bouaoud J, Bossi P, Elkabets M, et al. Unmet needs and perspectives in oral cancer prevention[J]. Cancers, 2022, 14(7): 1815.
|
6 |
梁甲武, 卫明慧, 刘青. 口腔潜在恶性病变癌变的早期无创检查方法[J]. 实用口腔医学杂志, 2018, 34(4): 557-560.
|
|
Liang JW, Wei MH, Liu Q. Early non-invasive examination methods for malignant transformation of potential oral lesions[J]. J Pract Stomatol, 2018, 34(4): 557-560.
|
7 |
Xu Y, Deng X, Sun Y, et al. Optical imaging in the diagnosis of OPMDs malignant transformation[J]. J Dent Res, 2022, 101(7): 749-758.
|
8 |
Fang J, Islam W, Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers[J]. Adv Drug Deliv Rev, 2020, 157: 142-160.
|
9 |
Shi Y, van der Meel R, Chen XY, et al. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy[J]. Theranostics, 2020, 10(17): 7921-7924.
|
10 |
Ikeda-Imafuku M, Wang LLW, Rodrigues D, et al. Stra-tegies to improve the EPR effect: a mechanistic perspective and clinical translation[J]. J Control Release, 2022, 345: 512-536.
|
11 |
Egloff-Juras C, Bezdetnaya L, Dolivet G, et al. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green[J]. Int J Nanomedicine, 2019, 14: 7823-7838.
|
12 |
Mieog JSD, Achterberg FB, Zlitni A, et al. Fundamentals and developments in fluorescence-guided cancer surgery[J]. Nat Rev Clin Oncol, 2022, 19(1): 9-22.
|
13 |
Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and Meta-analysis of malignant transformation rate by subtype[J]. Head Neck, 2020, 42(3): 539-555.
|
14 |
Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and Meta-analysis[J]. J Oral Pathol Med, 2018, 47(7): 633-640.
|
15 |
李晨曦, 施芷怡, 喻仲麟, 等. 口腔白斑病自体荧光成像结果与临床病理特征相关性分析[J]. 临床口腔医学杂志, 2023, 39(3): 153-157.
|
|
Li CX, Shi ZY, Yu ZL, et al. Correlation analysis between autofluorescence imaging results and clinicopathological characteristics of oral leukoplakia[J]. J Clin Stomatol, 2023, 39(3): 153-157.
|
16 |
王倩, 徐偲, 韩莹, 等. 甲苯胺蓝染色在口腔潜在恶性疾患及口腔鳞状细胞癌早期诊断中的临床应用价值研究[J]. 中国实用口腔科杂志, 2020, 13(12): 738-744.
|
|
Wang Q, Xu S, Han Y, et al. Clinical application value of toluidine blue staining in the early diagnosis of oral potential malignant disorders and oral squamous cell carcinoma[J]. Chin J Pract Stomatol, 2020, 13 (12): 738-744.
|
17 |
王映, 李志萍, 王浩然, 等. VELscope自体荧光检查在糜烂型口腔扁平苔藓诊断及恶变筛查中的应用研究[J]. 中国实用口腔科杂志, 2022, 15(2): 212-215.
|
|
Wang Y, Li ZP, Wang HR, et al. Application of VELscope autofluorescence examination in diagnosis and malignancy screening of erosive oral lichen planus[J]. Chin J Pract Stomatol, 2022, 15(2): 212-215.
|
18 |
Lee YJ, Krishnan G, Nishio N, et al. Intraoperative fluorescence-guided surgery in head and neck squamous cell carcinoma[J]. Laryngoscope, 2021, 131(3): 529-534.
|
19 |
王育新, 王志勇, 王永功, 等. 吲哚菁绿荧光成像技术在口腔鳞癌治疗中的应用: 中国专家共识[J]. 中国口腔颌面外科杂志, 2022, 20(1): 1-6.
|
|
Wang YX, Wang ZY, Wang YG, et al. Chinese expert consensus statement on the application of of indocyanine green (ICG) fluorescence imaging in the treatment of oral squamous cell carcinoma[J]. Chin J Oral Maxillofac Surg, 2022, 20(1): 1-6.
|
20 |
张誉, 季彤. 吲哚菁绿在口腔癌可视化治疗中的应用[J]. 口腔疾病防治, 2020, 28(2): 118-122.
|
|
Zhang Y, Ji T. Application of indocyanine green in visual treatment of oral cancer[J]. J Prev Treat Stomatol Dis, 2020, 28(2): 118-122.
|
21 |
Pan J, Deng H, Hu S, et al. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC[J]. World J Surg Oncol, 2020, 18(1): 96.
|
22 |
Wu ZH, Dong YC, Wang YX, et al. Clinical application of indocyanine green fluorescence navigation technology to determine the safe margin of advanced oral squamous cell carcinoma[J]. Gland Surg, 2022, 11(2): 352-357.
|
23 |
Vairaktaris E, Spyridonidou S, Papakosta V, et al. The hamster model of sequential oral oncogenesis[J]. Oral Oncol, 2008, 44(4): 315-324.
|
24 |
Wang ZD, Cormier RT. Golden Syrian hamster models for cancer research[J]. Cells, 2022, 11(15): 2395.
|
25 |
Xie DY, Wang YX, Wang ZY, et al. Kinetics analysis of indocyanine green based on a novel mouse model to distinguish between tumor and inflammation[J]. Anal Methods, 2019, 11(44): 5704-5710.
|
26 |
Pal R, Lwin TM, Krishnamoorthy M, et al. Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patients[J]. Nat Biomed Eng, 2023, 7(12): 1649-1666.
|